503b semaglutide ivy glp 1 IVY RX GLP-1 2026: Truth Behind the IVY RX Compounded Program semaglutide 503b semaglutide for office

( ) ( )

Both contain the same active ingredient

The news: Pushed by consumer demand and a shortage of the brand-name GLP-1 medications, WeightWatchers (WW) has joined a growing list of companies that will be offering compounded semaglutide (marketed by Novo Nordisk as Ozempic and Wegovy) to its members

Phase 2 Trial Data, What Researchers Are Working From The pivotal Phase 2 trial (Jastreboff et al., NEJM 2023, NCT04881760) enrolled 338 adults across six cohorts over 48 weeks

Weight reduction achieved through Ozempic treatmenttypically around 4-6% of body weight at doses used for type 2 diabetesmay help reduce cardiovascular burden